RAPHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Raphael Pharmaceutical Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.51+0.11 (+7.86%)
Close on Oct 16, 2026
- Market cap
- $30.47M
- P/E (TTM)
- 75.5
- Dividend yield
- –
Raphael Pharmaceutical statistics
Financials through Jun 30, 2026, price as of Oct 16, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison
Valuation
| Measure | Raphael Pharmaceutical | Industry median |
|---|---|---|
| Market Cap | $30.47M | $166.30M |
| Enterprise Value | $30.47M | $88.19M |
| PE Ratio | 75.50 | 20.44 |
Income (trailing twelve months)
| Measure | Raphael Pharmaceutical | Industry median |
|---|---|---|
| Operating Income | -$927.00K | -$21.40M |
| Net Income | -$980.00K | -$22.46M |
| EBITDA | -$927.00K | -$16.91M |
| EPS (Diluted) | $0.02 | -$0.83 |
Returns
| Measure | Raphael Pharmaceutical | Industry median |
|---|---|---|
| Return on Assets (ROA) | -5297.3% | -40.9% |
Growth
| Measure | Raphael Pharmaceutical | Industry median |
|---|---|---|
| EPS Growth (YoY) | -33.3% | -26.2% |
| EPS Growth (3Y CAGR) | -32.7% | -0.17% |
| EPS Growth (5Y CAGR) | 0.00% | 3.77% |
Balance sheet
| Measure | Raphael Pharmaceutical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.00K | $61.43M |
| Net Cash (Debt) | $1.00K | $15.35M |
| Net Cash Per Share | $0.00 | $0.66 |
| Equity (Book Value) | -$1.89M | $49.09M |
| Book Value Per Share | -$0.09 | $1.37 |
| Tangible Book Value | -$1.89M | $23.52M |
| Working Capital | -$1.89M | $76.81M |
Financial position
| Measure | Raphael Pharmaceutical | Industry median |
|---|---|---|
| Current Ratio | 0.00 | 3.34 |
| Quick Ratio | 0.00 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Raphael Pharmaceutical | Industry median |
|---|---|---|
| Operating Cash Flow | -$15.00K | -$12.35M |
Dividends and yields
| Measure | Raphael Pharmaceutical | Industry median |
|---|---|---|
| Earnings Yield | -3.22% | -23.3% |
Shares
| Measure | Raphael Pharmaceutical | Industry median |
|---|---|---|
| Shares Outstanding | 20,176,400 | 58,127,000 |
| Shares Change (YoY) | 4.05% | 10.9% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 9,953,200 | 49,136,700 |
| Shares Held by Insiders | 50.7% | 11.6% |
Scores
| Measure | Raphael Pharmaceutical | Industry median |
|---|---|---|
| Altman Z-Score | -2874.67 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Raphael Pharmaceutical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.